Koselugo 25mg Capsule contains an active component called Selumetinib. It is a medication used in the treatment of certain types of cancers, particularly melanoma (a type of skin cancer) and other solid tumors, including non-small cell lung cancer and ovarian cancer, especially in cases where there's a specific genetic mutation that makes the cancer cells sensitive to MEK inhibitors. It may be prescribed for patients with advanced melanoma that has a specific genetic mutation, often BRAF-mutant melanoma. It has shown promise in treating plexiform neurofibromas, tumors associated with NF1, a genetic disorder that causes tumors to grow on nerves. 

Individuals who have had a severe allergic reaction to Koselugo 25mg Capsule or any of its components should not take this medication. It may cause harm to an unborn baby, so it is not recommended for use during pregnancy. Patients with pre-existing heart conditions or a history of heart problems may need close monitoring or might not be suitable candidates for this medication. Older individuals, especially those over 65, may have an increased risk of certain side effects. Close monitoring for adverse reactions is typically recommended after taking this medication. The safety and efficacy of Koselugo 25mg Capsule in children under specific ages may not be well-established.

Melanoma Treatment.

Neurofibromatosis type 1 (NF1).

Solid Tumor Treatment.

Koselugo 25mg Capsule is a medication that targets a specific cellular pathway called the MEK pathway, which is crucial for regulating cell growth. In cancers like melanoma and certain tumors, it blocks this pathway, disrupting signals that promote uncontrolled cell growth. By inhibiting this pathway, it slows down or halts the progression of cancer cells, reducing tumor growth and spread.

Koselugo 25mg Capsule is primarily administered orally, typically as capsules. The healthcare provider will determine the dosage and duration of treatment based on the specific infection and individual factors.

Heart problems

Eye problems

Interstitial lung disease (ILD)

Liver problems

Skin toxicities

Nausea and vomiting

Diarrhea

Fatigue

Skin rash

Swelling or fluid retention

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with the Koselugo 25mg Capsule, reducing effectiveness by causing undesirable side effects.

Stored at controlled room temperature, between 20°C to 25°C

Keep away from moisture, heat, and light.

It should not be frozen.

Keep away from children and pets.

Regular monitoring of heart function, including ECGs and cardiac assessments, may be necessary due to potential heart-related side effects while using Koselugo 25mg Capsule. Periodic eye exams are recommended as this medication might cause vision changes or retinal vein occlusion. Patients require monitoring for signs of interstitial lung disease (ILD) or breathing difficulties. Monitoring liver function through blood tests is essential due to the potential for elevated liver enzymes or liver damage. Live vaccines should generally be avoided during treatment due to potential complications. Regular monitoring might be necessary for individuals with existing endocrine conditions. Discuss with a healthcare professional regarding other medications, including over-the-counter drugs, herbal supplements, or vitamins, to avoid potential interactions with this medication.